Eradicating H pylori

British Medical Journal

Volumn 328, Issue 7453, 2004, Pages 1388-1389

  Delaney, Brendan ^a   Moayyedi, Paul ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; DISEASE SEVERITY; DISINFECTION; DYSPEPSIA; EDITORIAL; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH CANCER; SYMPTOM;

EID: 2942731560     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.328.7453.1388     Document Type: Editorial

References (12)

1. Moayyedi P, Deeks J, Talley NJ, Delaney B, Forman D. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 2003;98:2621-6.
2. Chiba N, Veldhuyzen van Zanten SJO, Sinclair P, Ferguson RA, Escobedo S, Grace E. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment - Helicobacter pylori positive (CADET-Hp) randomised controlled trial. BMJ 2002;324:1012-6.
3. Scottish Intercollegiate Guidelines Network. Dyspepsia. A national clinical guideline. Edinburgh: SIGN, 2003. (Publication No 68.)
4. National Institute of Clinical Excellence. The management of dyspepsia in primary care. London: NICE (in press). www.nice.org.uk/ page.aspx?o=20078 (accessed 3 June 2004).
5. Harvey RF, Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project. BMJ 2004;328:1417-9.
6. Moayyedi P, Feltbower R, Brown J, Mason S, Mason J, Nathan J, et al. The effect of population H pylori screening and treatment on dyspepsia and quality of life in the community: results of a randomised controlled trial. Lancet 2000;355:1665-9.
7. Wildner-Christensen M, Hansen JM, Schaffalitzky de Muckadell OB. Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population. Gastroenterology 2003;125:372-9.
8. Vaira D, Vakil N, Rugge M, Gatta L, Ricci C, Menegatti M, et al. Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects. Gut 2003;52:1543-7.
9. Malfertheiner P, Dent J, Zeijlon L, Sipponen P, Veldhuyzen van Zanten SJ, Burman CF, et al. Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease - results from a randomized controlled trial programme. Aliment Pharmacol Ther 2002;16:1431-42.
10. Laine L, Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastro-esophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am J Gastroenterol 2002;97:2992-7.
11. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, Delaney B. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. BMJ 2000;321:659-64.
12. Schwizer W, Thumshirn M, Dent J, Guldenschuh I, Menne D, Cathomas G, et al. Helicobacter pylori and symptomatic relapse of gastrooesophageal reflux disease: a randomised controlled trial. Lancet 2001;357:1738-42.